Memphis, Tennessee, United States
Luminetx Corp. today announced it has launched the next generation of the VeinViewer - the VeinViewerGS. This "Global Standard" model was specifically designed to meet the rigorous quality requirements for the international marketplace.
From today forward, the GS model will be offered to both international and domestic clients as Luminetx's flagship product. According to the company, this model was born as a result of the Luminetx global expansion strategy allowing Luminetx to market and sell the VeinViewer outside of the United States.
"Clinically speaking, this is the same technological powerhouse that's been on the market for the last year," said Chris Schnee, vice president of global marketing for Luminetx. "So our domestic clients can rest assured that their current device is still as leading-edge and as relevant as the GS model is today."
The VeinViewer is a vascular imaging system that allows physicians, nurses and other health care professionals to clearly see accessible vasculature (or lack thereof) in real time. The device uses a combination of near-infrared light and patented technologies to image vascular structures and projects their location directly on the surface of the skin. This provides clinicians with a safe, non-invasive adjunct technology for clinical treatments and procedures including, but not limited to: IV insertions, PICC line insertions, routine venipuncture (blood sampling), blood and plasma donations and treatment for varicose and spider veins.
In December 2007, the VeinViewer technology received EC and ISO 13485:2003 certifications - thus allowing shipment to European countries and continuing the expansion of the Luminetx global strategy. International distribution contract negotiations and deals are well under way, Schnee added, and the company expects first overseas commercial shipments of the GS model within the next several weeks.
"This milestone signals our entering the international marketplace, so this is an important day for our company and for patients here in the United States and abroad," said Rodney Schutt, chief operating officer at Luminetx. "As our company mission states: 'Every patient, Every time, Everywhere,' this product evolution and international outreach move us closer to our goal of bettering patient care worldwide."
About Luminetx
Based in Memphis, Tenn., Luminetx Corporation discovers, develops and commercializes medical product and biometric technologies. The company's premier product, VeinViewer, is now available and in use nationwide. For more information on Luminetx and VeinViewer, visit www.luminetx.com.
Source: Business Wire (Business Wire India)